The tissue analysis device maker, a spinout from Stanford University, has selected the Nasdaq Global Select Market for its initial public offering.
Akoya Biosciences, a US-based tissue analysis technology developer spun out of Stanford University, has filed to raise $115m in an initial public offering on the Nasdaq Global Select Market.
Founded in 2015, Akoya has built a tissue analysis technology platform called Codex which allows users to analyse tissue cells and create images of more than 40 protein markers within them at a single-cell resolution.
The technology was developed in a laboratory at Stanford University overseen by Akoya…
